Serial Number | 98332399 |
Word Mark | SURESTATION |
Filing Date | Wednesday, December 27, 2023 |
Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
Status Date | Tuesday, October 29, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, September 3, 2024 |
Pseudo Mark | SURE STATION |
Goods and Services | Biotechnology research and development services for others, namely, mammalian cell line development, monoclonal antibody development, genome sequencing, genome mapping, genome and nucleic acid analysis, genome amplification, genome scanning, and high performance computing services for genome sequencing |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, December 27, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | KBI Biopharma, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Durham, NC 27704 |
Party Name | KBI Biopharma, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Durham, NC 27704 |
Event Date | Event Description |
Wednesday, December 27, 2023 | NEW APPLICATION ENTERED |
Wednesday, April 10, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, July 26, 2024 | ASSIGNED TO EXAMINER |
Friday, July 26, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, August 14, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 3, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, September 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, October 29, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |